Skip to main content
. 2025 Oct 24;15(11):11351–11362. doi: 10.21037/qims-2024-2504

Table 2. Univariate and multivariable Cox regression analysis of clinical and imaging predictors for MACE in training cohort.

Variables Univariate analysis Multivariable analysis 1 Multivariable analysis 2
HR 95% CI P value HR 95% CI P value HR 95% CI P value
Age 1.05 1.01–1.08 0.005 1.05 1.01–1.09 0.008 1.06 1.02–1.10 0.005
Females 1.38 0.68–2.83 0.377
BMI 0.98 0.90–1.08 0.699
Hypertension history 0.95 0.47–1.89 0.877
Diabetes history 2.15 1.13–4.08 0.019 2.12 1.11–4.07 0.023 2.03 1.06–3.90 0.034
Dyslipidemia history 1.04 0.56–1.93 0.910
CAD history 2.25 1.07–4.72 0.033 2.08 0.98–4.39 0.056 2.00 0.94–4.24 0.072
Smoking history 0.77 0.41–1.43 0.402
AICVD history 1.08 0.55–2.13 0.818
Family history of cardiovascular disease 0.98 0.51–1.90 0.959
Systolic BP 1.01 0.99–1.02 0.521
Diastolic BP 0.99 0.96–1.02 0.439
NIHSS 0.97 0.87–1.08 0.616
Water swallow test 0.51 0.22–1.22 0.132
Glycated hemoglobin 1.07 0.90–1.28 0.432
Fast glucose 1.10 1.00–1.22 0.047 1.04 0.92–1.18 0.529 1.03 0.91–1.17 0.631
Triglyceride 0.86 0.58–1.28 0.465
TC 0.91 0.66–1.26 0.588
HDL-C 0.44 0.12–1.64 0.219
LDL-C 0.95 0.66–1.37 0.788
Homocysteine 0.99 0.95–1.02 0.498
Fibrinogen 0.92 0.66–1.28 0.636
D-dimer 1.04 0.98–1.11 0.213
TOAST 1.60 0.74–3.47 0.234
CT-FFR ≤0.80 4.30 1.32–13.94 0.015 3.52 1.08–11.48 0.037
CAS 1.20 1.09–1.33 <0.001 1.22 1.10–1.36 <0.001 1.21 1.08–1.35 0.001
Significant coronary stenosis 1.24 0.59–2.60 0.576
CACS (level) 1.62 1.14–2.31 0.007 1.25 0.86–1.82 0.244 1.10 0.74–1.62 0.636

AICVD, acute ischemic cerebrovascular disease; BMI, body mass index; BP, blood pressure; CACS, coronary artery calcium score; CAD, coronary artery disease; CAS, cerebral atherosclerosis score; CI, confidence interval; CT-FFR, coronary computed tomography-derived fractional flow reserve; HDL-C, high-density lipoprotein cholesterol; HR, hazard ratio; LDL-C, low-density lipoprotein cholesterol; NIHSS, National Institutes of Health Stroke Scale; TC, total cholesterol; TOAST, Trial of ORG 10172 in Acute Stroke Treatment.